Teens with de novo acute lymphoblastic leukemia: Efficacy and safety of a pediatric protocol versus one adult;Adolescentes con leucemia aguda linfoblástica de novo: Eficacia y seguridad de un protocolo pediátrico versus uno de adultos

Gaceta Medica de Mexico

Volumn 144, Issue 6, 2008, Pages 485-489

  López Hernández, Manuel Antonio ^a   Alvarado Ibarra, Martha ^a   Jiménez Alvarado, Rosa María ^a   De Diego Flores, José Enrique ^a   González Avante, Crescencio Mauricio ^a  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

Author keywords

Adolescents; Chemotherapy; Lymphoblastic acute leukemia

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; FEMALE; HUMAN; MALE;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL PROTOCOLS; FEMALE; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

EID: 61549125399     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pullen J, Schuster JJ, Borowitz M, Amylon M, Carroll AJ, Land V, et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG Study). Leukemia 1999;13:1696-1707.
2. Radich JP. Philadelphia chromosome-positive acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001;15:21-36.
3. Bleyer WA, Tejeda H, Murphy SB, Robison LL, Pollock BH, Severson RK, et al. National cancer clinical trials: Children have equal access; adolescents not. J Adolesc Health 1997;21(6):374-375.
4. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Sculman P, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 1995;85:2025-2037.
5. Kantarjian HM, O'Brien S, Smith TL, Cortés J, Giles FJ, Beran M, et al. Results of treatment with hyper-CVAD, a dose intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000;18:547-561.
6. th edition. Washington, DC: The American Society of Hematology; 2005, pp. 123-130.
7. Ruiz-Argüelles G, Apreza-Molina MG. Resultados del tratamiento de leucemias agudas en adolescentes. Rev Invest Clin 1997;49:271-275.
8. th edition. New York: McGraw-Hill; 2001, pp. 1141-1161.
9. Santana VM, Crist WM, Rivera GK, Look AT, Behm FG, Raimondi SC, et al. Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia. Leukemia 1990;4(2):87-90.
10. Nachman JB. Adolescents with acute lymphoblastic leukemia: a new "age". Rev Clin Exp Hematol 2003;7(3):261-269.
11. Nachman JB. Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukemia. Br J Haematol 2005;130(2):166-173.
12. Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, et al. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from trails ALL-BFM 86, 90 and 95. Klin Padiatr 2005;217(6):310-320.
13. Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T, et al. Should adolescents with acute lymophoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003;21:774-780.
14. Schroder H, Kjeldstad M, Boesen AM, Nielsen OJ, Schmidt KG, Johnsen HE, et al. Acute lymphoblastic leukemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukemia be treated in the same way as children? Ugeskr Laeger 2006;168(26-32):2554-2558.
15. Schroder H, Kjeldstad M, Boesen AM, Nielsen OJ, Schmidt KG, Johnsen HE, et al. Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark. Secundary publication. Dan Med Bull 2006;53(1):76-79.
16. Hallböök H, Gustafsson G, Smedmyr B, Söderhäll S, Heyman M. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer 2006;107(7):1551-1561.
17. Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol 2007;25(7):813-819.
18. Ramanujachar R, Richards S, Hann I, Webb D. Adolescents with acute lymphoblastic leukemia: emerging from the shadow of pediatric and adult treatment protocols. Pediatric Blood Cancer 2006;47(6):748-756.